LAST CHANCE to register for the IASLC 2020 Targeted Therapies in Lung Cancer Meeting (to be held THIS WEEK February 17-20). The program is a series of 5-minute presentations on lab research and clinical trials for targeted therapies. The session on ALK & ROS1 inhibitors happens on Thursday February 18 at 14:40 Eastern Time.
This virtual meeting is a great opportunity to get an overview of what’s happening in lung cancer targeted therapies. Normally attendance is severely limited due to the small meeting space.
Registration is FREE for patient advocates, lung cancer survivors (anyone ever diagnosed with lung cancer) and caregivers. You must also be a member of IASLC to register (IASLC membership is free for patients and caregivers).
Hope to “see” you there!